Quinazolin-4-one Coupled with Pyrrolidin-2-iminium Alkaloids from Marine-Derived Fungus <em>Penicillium aurantiogriseum</em>

Huanqin Dai,Hua Bai,Jidong Wang,Mei Liu,Yaojun Tong,Xueting Liu,Hong Gao,Na Yang,Hui Guo,Ke Yu,Caixia Chen,Fuhang Song,Biao Ren,Lixin Zhang

DOI: https://doi.org/10.3390/md10061297

2012-01-01

Marine Drugs

Abstract:Three new alkaloids, including auranomides A and B (<strong>1</strong> and <strong>2</strong>), a new scaffold containing quinazolin-4-one substituted with a pyrrolidin-2-iminium moiety, and auranomide C (<strong>3</strong>), as well as two known metabolites auranthine (<strong>4</strong>) and aurantiomides C (<strong>5</strong>) were isolated from the marine-derived fungus <em>Penicillium aurantiogriseum</em>. The chemical structures of compounds <strong>1</strong>–<strong>3</strong> were elucidated by extensive spectroscopic methods, including IR, HRESIMS and 2D NMR spectroscopic analysis. The absolute configurations of compounds <strong>1</strong>–<strong>3</strong> were suggested from the perspective of a plausible biosynthesis pathway. Compounds <strong>1</strong>–<strong>3</strong> were subjected to antitumor and antimicrobial screening models. Auranomides A–C exhibited moderate cytotoxic activity against human tumor cells. Auranomides B was the most potent among them with an IC₅₀ value of 0.097 μmol/mL against HEPG2 cells.